Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

NCT04985318 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Acquired Thrombotic Thrombocytopenic Purpura

Interventions

DRUG: Cablivi®

Sponsor

University of Cologne